Phong Phu Pharmaceutical JSC (HNX:PPP)

Market Cap	164.56B +13.3%
Revenue (ttm)	139.83B +1.7%
Net Income	18.55B +6.9%
EPS	1,884.00 +6.6%
Shares Out	8.80M
PE Ratio	9.93
Forward PE	n/a
Dividend	1,500.00 (8.02%)
Ex-Dividend Date	Mar 19, 2026

Volume	300
Average Volume	923
Open	18,300
Previous Close	18,100
Day's Range	18,300 - 18,700
52-Week Range	17,300 - 23,100
Beta	0.04
RSI	47.21
Earnings Date	Apr 24, 2026

About HNX:PPP

Phong Phu Pharmaceutical Joint Stock Company engages in the production, sale, and distribution of medicines primarily in Vietnam. The company’s medicines are derived from medicinal herbs, pharmaceutical chemicals, and health protection food, that are offered in tablets, film-coated, sugar-coated, soft capsules, granules, powder, and other forms. It offers its products for respiratory, spiritual, anti-inflammatory, anti-allergic, digest, cardiovascular, diabetes, liver function, and osteoarthritis, as well as provides vitamins and minerals. Phon...

• Industry: Pharmaceutical Preparations
• Founded: 2000
• Employees: 212
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: PPP

Financial Performance

In 2025, HNX:PPP's revenue was 139.83 billion, an increase of 1.66% compared to the previous year's 137.55 billion. Earnings were 18.55 billion, an increase of 19.34%.